• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
COVID-19 convalescent plasma transfusion.新型冠状病毒肺炎康复者恢复期血浆输注
Hematol Transfus Cell Ther. 2020 Apr-Jun;42(2):113-115. doi: 10.1016/j.htct.2020.04.003. Epub 2020 Apr 17.
2
A 63-Year-Old Woman with SARS-CoV-2 Infection, Who Developed Severe COVID-19 Pneumonia and Was Supported with Convalescent Plasma Therapy.一名63岁感染严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的女性，她发展为重症冠状病毒病2019（COVID-19）肺炎并接受了恢复期血浆治疗。
Am J Case Rep. 2020 Sep 29;21:e927662. doi: 10.12659/AJCR.927662.
3
Convalescent plasma to treat coronavirus disease 2019 (COVID-19): considerations for clinical trial design.恢复期血浆治疗 2019 冠状病毒病（COVID-19）：临床试验设计的考虑因素。
Transfusion. 2020 Jun;60(6):1123-1127. doi: 10.1111/trf.15843. Epub 2020 May 12.
4
Treatment of COVID-19: Perspective on Convalescent Plasma Transfusion.新型冠状病毒肺炎的治疗：恢复期血浆输注的前景
Front Med (Lausanne). 2020 Jul 28;7:435. doi: 10.3389/fmed.2020.00435. eCollection 2020.
5
Points to consider in the preparation and transfusion of COVID-19 convalescent plasma.新型冠状病毒肺炎康复者恢复期血浆制备及输注的注意事项。
Vox Sang. 2020 Aug;115(6):485-487. doi: 10.1111/vox.12939. Epub 2020 May 14.
6
Unusual Cardiac Presentation of COVID-19 and Use of Convalescent Plasma.新冠病毒肺炎的不典型心脏表现及恢复期血浆的应用
Case Rep Cardiol. 2020 Oct 2;2020:8863195. doi: 10.1155/2020/8863195. eCollection 2020.
7
Blood Banking and Transfusion Medicine Challenges During the COVID-19 Pandemic.新冠疫情期间的血液库与输血医学挑战
Clin Lab Med. 2020 Dec;40(4):587-601. doi: 10.1016/j.cll.2020.08.013. Epub 2020 Aug 8.

引用本文的文献

1
Clinical nursing care protocol for convalescent plasma transfusion in patients with COVID-19.新型冠状病毒肺炎患者恢复期血浆输注的临床护理方案
Int J Afr Nurs Sci. 2023;18:100518. doi: 10.1016/j.ijans.2022.100518. Epub 2022 Dec 13.
2
Increased Levels of Autoantibodies against ROS-Modified Proteins in Depressed Individuals with Decrease in Antibodies against SARS-CoV-2 Antigen (S1-RBD).抑郁症患者中针对ROS修饰蛋白的自身抗体水平升高，同时针对SARS-CoV-2抗原（S1-RBD）的抗体减少。
Curr Issues Mol Biol. 2022 Oct 28;44(11):5260-5276. doi: 10.3390/cimb44110358.
3
Effect of Convalescent Plasma Therapy on Clinical Improvement of COVID-19 Patients: A Randomized Clinical Trial.康复期血浆治疗对新冠病毒肺炎患者临床改善的影响：一项随机临床试验。
Tanaffos. 2022 Jan;21(1):24-30.
4
'Convalescent Plasma'- An Effective Treatment Option to Prevent Emerging nCOVID-19- A Review.“恢复期血浆”——预防新型冠状病毒肺炎的一种有效治疗选择——综述
Infect Disord Drug Targets. 2022;22(8):42-60. doi: 10.2174/1871526522666220425103031.
5
Convalescent Plasma for the Prevention and Treatment of COVID-19: A Systematic Review and Quantitative Analysis.恢复期血浆用于 COVID-19 的预防和治疗：系统评价和定量分析。
JMIR Public Health Surveill. 2021 Apr 7;7(4):e25500. doi: 10.2196/25500.
6
Influence of obesity on serum levels of SARS-CoV-2-specific antibodies in COVID-19 patients.肥胖对 COVID-19 患者血清中 SARS-CoV-2 特异性抗体水平的影响。
PLoS One. 2021 Mar 24;16(3):e0245424. doi: 10.1371/journal.pone.0245424. eCollection 2021.
7
Convalescent Plasma Therapy for Management of COVID-19: Perspectives and Deployment in the Current Global Pandemic.用于治疗新型冠状病毒肺炎的恢复期血浆疗法：当前全球大流行中的观点与应用
Risk Manag Healthc Policy. 2020 Nov 23;13:2707-2728. doi: 10.2147/RMHP.S281388. eCollection 2020.
8
A patient affected by critical COVID-19 pneumonia, successfully treated with convalescent plasma.一名患有重症新型冠状病毒肺炎的患者，通过恢复期血浆治疗成功康复。
Transfus Apher Sci. 2020 Dec;59(6):102995. doi: 10.1016/j.transci.2020.102995. Epub 2020 Nov 5.
9
Convalescent Plasma against COVID-19: A Broad-Spectrum Therapeutic Approach for Emerging Infectious Diseases.康复期血浆治疗新冠病毒病：应对新发传染病的广谱治疗方法
Microorganisms. 2020 Nov 5;8(11):1733. doi: 10.3390/microorganisms8111733.
10
Convalescent plasma appears efficacious and safe in COVID-19.康复期血浆疗法在治疗新冠肺炎方面似乎有效且安全。
Ther Adv Infect Dis. 2020 Sep 28;7:2049936120957931. doi: 10.1177/2049936120957931. eCollection 2020 Jan-Dec.

本文引用的文献

1
Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma.5 例危重症 COVID-19 患者接受恢复期血浆治疗。
JAMA. 2020 Apr 28;323(16):1582-1589. doi: 10.1001/jama.2020.4783.
2
Covid-19: FDA approves use of convalescent plasma to treat critically ill patients.新冠疫情：美国食品药品监督管理局批准使用康复期血浆治疗重症患者。
BMJ. 2020 Mar 26;368:m1256. doi: 10.1136/bmj.m1256.
3
Treatment of COVID-19: old tricks for new challenges.2019冠状病毒病的治疗：应对新挑战的老办法
Crit Care. 2020 Mar 16;24(1):91. doi: 10.1186/s13054-020-2818-6.
4
The convalescent sera option for containing COVID-19.使用康复期血清来控制新型冠状病毒肺炎。
J Clin Invest. 2020 Apr 1;130(4):1545-1548. doi: 10.1172/JCI138003.
5
Potential interventions for novel coronavirus in China: A systematic review.中国新型冠状病毒潜在干预措施的系统评价。
J Med Virol. 2020 May;92(5):479-490. doi: 10.1002/jmv.25707. Epub 2020 Mar 3.
6
The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis.恢复期血浆和高效免疫球蛋白治疗病毒性病因严重急性呼吸道感染的有效性：系统评价与探索性Meta分析
J Infect Dis. 2015 Jan 1;211(1):80-90. doi: 10.1093/infdis/jiu396. Epub 2014 Jul 16.
7
Hyperimmune IV immunoglobulin treatment: a multicenter double-blind randomized controlled trial for patients with severe 2009 influenza A(H1N1) infection.静注人免疫球蛋白（pH4）治疗严重 2009 年甲型 H1N1 流感的多中心、双盲、随机对照临床研究
Chest. 2013 Aug;144(2):464-473. doi: 10.1378/chest.12-2907.
8
Convalescent plasma treatment reduced mortality in patients with severe pandemic influenza A (H1N1) 2009 virus infection.恢复期血浆治疗可降低严重大流行流感 A（H1N1）2009 病毒感染患者的死亡率。
Clin Infect Dis. 2011 Feb 15;52(4):447-56. doi: 10.1093/cid/ciq106. Epub 2011 Jan 19.
9
Meta-analysis: convalescent blood products for Spanish influenza pneumonia: a future H5N1 treatment?荟萃分析：用于西班牙流感肺炎的恢复期血液制品：未来治疗H5N1的方法？
Ann Intern Med. 2006 Oct 17;145(8):599-609. doi: 10.7326/0003-4819-145-8-200610170-00139. Epub 2006 Aug 29.
10
Use of convalescent plasma therapy in SARS patients in Hong Kong.香港严重急性呼吸系统综合症患者康复期血浆疗法的应用。
Eur J Clin Microbiol Infect Dis. 2005 Jan;24(1):44-6. doi: 10.1007/s10096-004-1271-9.

COVID-19 convalescent plasma transfusion.

作者信息

Langhi Dante Mário, Santis Gil Cunha De, Bordin José Orlando

机构信息

Universidade Federal de São Paulo (UNIFESP), São Paulo, SP, Brazil.

Fundação Hemocentro de Ribeirão Preto, Ribeirão Preto, SP, Brazil.

出版信息

Hematol Transfus Cell Ther. 2020 Apr-Jun;42(2):113-115. doi: 10.1016/j.htct.2020.04.003. Epub 2020 Apr 17.

DOI:10.1016/j.htct.2020.04.003
PMID:32313872
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7164882/
Abstract
摘要